NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









STAQ Pharma

STAQ Pharma

Private
Denver, ColoradoHealthcare & Life Scienceshttps://staqpharma.com/

Last Round

Grant

Apr 22, 2025

Est. Valuation

$183M

Total Funding Raised

$87.06M

Company Overview

STAQ Pharma is a pharmaceutical company that operates as an FDA-registered 503B outsourcing facility providing sterile, ready-to-use injectable medications to hospitals and healthcare systems.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Biotechnology, Compliance, Quality Management

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

503B outsourcingsterile compoundingsterile injectable medicationsdrug shortage solutionshospital pharmacy supplycompounded sterile preparationsready-to-administer medicationsFDA-registered facilitypharmaceutical manufacturingpharmacy outsourcinghospital supply chainbatch productionsterile manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

STAQ Pharma Comparables

Compare STAQ Pharma with similar companies based on industry and business-model similarity.

STAQ Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Leiters Health
91%
SCA Pharma
87%
Medivant Healthcare
87%

STAQ Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 22, 2025
Series DSep 1, 2024
Series DJun 20, 2023
Series CMar 2, 2022
Series BMar 31, 2021
Debt
Jan 5, 2021

Key People

Founding team and executive leadership

David Colson

Chief Financial Officer

Executive Team

STAQ Pharma Investors

Notable investors and investment history

STAQ Pharma investors
InvestorRounds
University Hospitals VenturesSeries C
Angels for ChangeGrant
Rev1 VenturesSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2025

    Received grant funding to support operations.

  • Feb 28, 2025

    Added Yale New Haven Health Service Corp. as a customer.

STAQ Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

STAQ Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about STAQ Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersDenver, Colorado
Employee Range117
Year Founded2018
Last FundingApr 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.